EMA has published Q&A document to prepare manufacturers for the UK's withdrawal from the EU with reg...
Read moreA one stop shop for joint advice between EMA, EUnetHTA and health technology assessment bodies - the...
Read moreGiven that the UK has formally announced its decision to leave the EU, what are the implications for...
Read moreMEAs are also known by other names such as risk-sharing agreements, value-added services, and result...
Read moreThe lack of a biosimilar market in the US is largely due to the substantial patent litigations which...
Read moreThis process aims to be completely transparent , to enable faster patient access to oncology treatme...
Read moreBoth payers and physicians do not believe that at the current prices Praluent and Repatha offer sign...
Read moreMulti-criteria decision analysis (MCDA) is a potentially useful tool that can be used to support dec...
Read moreNICE has recently published a consultation on changes to its appraisal process to "fast track" some ...
Read moreThis analysis compares the different methods of seeking payer scientific advice, including EMA joint...
Read more